For Cigna PPO and HMO members across California — including Boeing employees, Microsoft employees, and other Fortune-500 employer-group plans administered by Cigna or by Evernorth, Cigna’s behavioral-health arm. We verify your Cigna benefits at no cost, file prior authorization, and advocate through peer-to-peer review and California Independent Medical Review when the level of care your clinical assessment supports is challenged.
In most cases, yes. Cigna Healthcare — the health-benefits brand of The Cigna Group — is a top-five US commercial carrier. Boeing’s standard medical plan is administered through Cigna for many employee groups, with behavioral-health benefits typically routed through Evernorth, Cigna’s behavioral-health subsidiary. Most Cigna PPO and HMO plans cover medical detox, residential treatment, MAT, partial hospitalization, intensive outpatient, and structured aftercare. Our utilization-review team verifies your Cigna benefits at no cost and sends a written breakdown — covered levels of care, expected length-of-stay authorization, and any cost-sharing — typically within 30 minutes.
If your card lists Cigna, Cigna Healthcare, Evernorth, or references The Cigna Group, this is the verification path that applies to you.
Most Cigna-administered plans cover the levels of care across the substance-use treatment continuum. Specifics depend on your plan tier and any prior-authorization requirements your employer group has set. Typical authorization windows we see:
Specific authorization length depends on your plan, the clinical assessment at intake, and concurrent-review decisions Evernorth’s utilization-management team makes during your stay. Medical necessity is documented in clinical language at every concurrent-review window.
Coverage is the door; the clinical work happens after you walk through it. Boeing engineers, technicians, and corporate professionals on Cigna PPO arrive with specific work, family, and timing constraints — return-to-shift expectations, security-clearance considerations for some roles, FMLA paperwork, manager confidentiality. The clinical work has to fit alongside that reality.
The difference between a covered admission and a clinically meaningful one comes down to the items above.
Cigna’s utilization management for substance-use treatment runs primarily through Evernorth, the carrier’s behavioral-health subsidiary. Concurrent-review windows run on a 5-to-7-day cadence for residential stays. Our utilization-review and billing team handles the full cycle — from initial verification through California IMR or ERISA-track external review if needed.
The decision to escalate is not commercial. It’s clinical. When a client is denied care that’s clinically indicated, we advocate for them — through every step above — to support coverage of the level of care our team believes is medically appropriate.
Two pieces of law shape what Cigna — or any commercial behavioral-health carrier — is required to cover for California residents.
When we appeal a Cigna denial, the appeal is built on the clinical documentation and the law. Both sides matter.
The 28-day length of stay didn’t come from research. It came from old insurance benefit design and stuck. The National Institute on Drug Abuse, summarizing decades of research in its Principles of Effective Treatment, states that participation in treatment for less than 90 days is of limited effectiveness for most substance-use disorders, and that better outcomes are associated with longer durations of treatment. This includes time across the full continuum — detox, residential, PHP, IOP, and continuing care.
This is why we build for length-of-stay flexibility. Some Cigna members — Boeing engineers, Microsoft staff, and other tech-and-aerospace professionals — need a focused inpatient stay because of operational windows or family timing, then continue at PHP or IOP. Others — those with severe withdrawal risk, complex psychiatric comorbidity, or chronic relapse history — need extended residential care. The right length of stay is a clinical decision, not a calendar decision.
When concurrent review tries to cut a stay short, our UR and medical teams document the clinical reasoning, file the peer-to-peer request, and pursue appeals — including California IMR — when warranted.
Cigna is a top-five US commercial carrier with broad coverage across employer groups. Some of the populations whose plans we commonly verify:
If your card lists Cigna, Cigna Healthcare, or Evernorth, our UR team can walk through the verification with you — including confirmation of which Cigna plan structure applies to your employer.
Three steps. No commitment.
In most cases, yes. Boeing’s standard medical plan is administered through Cigna for many employee groups, with behavioral-health benefits routed through Evernorth. Coverage typically includes medical detox, residential treatment, MAT, PHP, IOP, and aftercare. Our UR team verifies the specifics of your Boeing-Cigna plan before admission.
Evernorth is The Cigna Group’s behavioral-health benefit administrator. For most Cigna commercial plans, behavioral-health utilization management — prior authorization, concurrent review, peer-to-peer review — is handled by Evernorth rather than Cigna’s medical-side team. Our UR team contacts Evernorth directly for behavioral-health verification.
Yes. Most Cigna commercial plans cover substance-use treatment in California. California’s SB 855 requires state-regulated commercial plans to cover medically necessary treatment for substance-use disorders. Our UR team verifies the specific cost-sharing your plan applies before admission.
Most Cigna plans cover medical detox when medically indicated. Authorization windows we typically see are 3 to 12 days, depending on substance, withdrawal severity, and medical or psychiatric complexity.
Most Cigna PPO and HMO plans require prior authorization for medical detox and residential admission. Our UR team files the prior-auth request with clinical documentation supporting medical necessity, typically before admission.
Our medical director conducts a peer-to-peer review with Evernorth’s medical director. If the denial holds, we file Level-1 and Level-2 internal appeals. When internal appeals are exhausted, we handle external appeals — California IMR for state-regulated plans, or ERISA-track external review for self-funded employer plans (common with Boeing’s largest divisions).
Most Cigna plans cover MAT for opioid use disorder (buprenorphine, naltrexone) and alcohol use disorder (naltrexone, acamprosate) when prescribed as part of a clinical treatment plan. Cigna’s prescription benefit through Express Scripts covers most standard MAT formulary lines.
Most Cigna plans cover treatment of co-occurring psychiatric conditions alongside substance-use treatment when both are clinically indicated, per federal MHPAEA parity requirements.
One call. Our UR team handles the Cigna verification end-to-end and reports back. Verification is free, confidential, and not a commitment to admit.
References to Cigna Healthcare, The Cigna Group, Evernorth, Express Scripts, Boeing, and Microsoft are made for informational purposes only; we are not affiliated with or endorsed by any of these organizations. Insurance acceptance is subject to benefit verification. Treatment outcomes vary by individual; statements about the authorization, peer-to-peer, and appeals process describe Gev’s Recovery’s standard practices and do not guarantee specific coverage decisions by your plan. Gev’s Recovery Center · 19448 Lassen St, Northridge, CA 91324 · CA DHCS license #191288AP.
